• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
KE Wenbing,CHEN Yansheng.To observe the curative effect of thymosin in treatment of liver cirrhosis complicated with spontaneous bacterial peritonitis.[J].Journal Of Pharmaceutical Research,2017,36(1):56-58[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3593times   Download 2990次 QR Code for this article
Scan with your phone!
胸腺肽治疗肝硬化并发自发性腹膜炎的疗效观察
柯文炳,陈焱生
Font:Larger+|Default|Smaller-
(鄂东医疗集团市中医医院<市传染病医院>,湖北 黄石 435003)
摘要:
目的 观察临床上应用胸腺肽对肝硬化并发自发性腹膜炎的治疗效果。方法 入选我院住院治疗的98例肝硬化并发自发性腹膜炎患者,随机分为治疗组(n=55)和对照组(n=43),两组均给予两周疗程的抗感染(三代头孢)、护肝、利尿、白蛋白和血浆支持等综合治疗,在此基础上,治疗组加用αl胸腺肽1.6 mg,皮下注射,隔日一次。观察并记录两组患者治疗前后腹水PMN计数和腹围大小,以及治疗期间患者不良反应发生情况。结果 治疗组在痊愈率(32.7%vs23.3%,χ2=3.914,P=0.043)、总有效率(85.4%vs72.1%,χ2=34.065,P=0.038)方面均优于对照组,组间比较具有统计学意义(P<0.05);此外,治疗组在腹水PMN计数下降和腹围缩小等方面均显著高于对照组(P<0.05或P<0.01)。结论 胸腺肽在治疗肝硬化并发自发性腹膜炎方面临床疗效良好,尤其在症状改善和腹水消退等控制病情方面具有一定的临床价值。
关键词:  胸腺肽  肝硬化  自发性细菌性腹膜炎
DOI:10.13506/j.cnki.jpr.2017.01.016
基金项目:
To observe the curative effect of thymosin in treatment of liver cirrhosis complicated with spontaneous bacterial peritonitis.
KE Wenbing,CHEN Yansheng
(Edong Healthcare Huangshi TCM Hospital,Huangshi 435003,China)
Abstract:
Objective To observe the clinical application effect of thymosin treatment of liver cirrhosis complicated with spontaneous bacterial peritonitis.Methods 98 cases of cirrhosis complicated with spontaneous bacterial peritonitis in our hospital were enrolled,and randomly divided into treatment group (n=55) and control group (n=43).Anti-infection of the two groups were given two weeks of treatment (three generation cephalosporins),protecting liver,diuresis,plasma albumin and supportive treatment.On this basis,the treatment group was treated with thymosin alpha l 1.6 mg,subcutaneous injection,once every two days.Observe and record the two groups of patients before and after treatment of ascites PMN count and abdominal circumference size,and the occurrence of adverse reactions during treatment of patients.Results The treatment group in the cure rate (32.7%vs23.3%,χ2=3.914,P=0.043),the total effective rate (85.4%vs72.1%,χ2=34.065,P=0.038) were better than the control group,comparison between groups was statistically significant (P<0.05);In addition,the treatment group in the ascites decreased PMN count and waist circumference were significantly higher than that the control group of narrow etc. (P<0.05 or P<0.01).Conclusion Thymosin good clinical efficacy in the treatment of liver cirrhosis complicated with spontaneous peritonitis, especially had certain clinical value in improving symptoms and disease control ascites.
Key words:  Thymosin  Cirrhosis  Spontaneous bacterial peritonitis
Today's Visits:464    Total Visits:2383159
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.